Drug Interactions between Ibrance and Vitamin D3
This report displays the potential drug interactions for the following 2 drugs:
- Ibrance (palbociclib)
- Vitamin D3 (cholecalciferol)
Interactions between your drugs
No interactions were found between Ibrance and Vitamin D3. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Ibrance
A total of 468 drugs are known to interact with Ibrance.
- Ibrance is in the drug class CDK 4/6 inhibitors.
- Ibrance is used to treat the following conditions:
Vitamin D3
A total of 77 drugs are known to interact with Vitamin D3.
- Vitamin d3 is in the drug class vitamins.
- Vitamin d3 is used to treat the following conditions:
Drug and food interactions
palbociclib food
Applies to: Ibrance (palbociclib)
Palbociclib oral capsules (Ibrance) should be taken with food to help with its absorption. Palbociclib oral tablets (Ibrance) may be taken with or without food. Do not consume grapefruit or grapefruit juice during treatment with palbociclib. Grapefruit and grapefruit juice can interact with palbociclib and increase the levels of palbociclib in your body. You may be more likely to experience side effects such as nausea; vomiting; diarrhea; loss of appetite; mouth sores; hair loss; weakness; pain, numbness, or tingling in the hands and feet; and impaired bone marrow function resulting in low numbers of different types of blood cells, which can increase the risk of anemia, bleeding problems, and infections. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.